HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intensive insulin therapy for Japanese patients with type 2 diabetes mellitus--results in the patients from single hospital.

AbstractOBJECTIVE:
We investigated the clinical characteristics of intensive insulin therapy in Japanese type 2 diabetes patients who commenced intensive insulin therapy during the in-hospital diabetes education program at Tokai university hospital.
METHODS:
81 type 2 diabetes patients who received intensive insulin therapy and in-hospital diabetes education program were examined their clinical features.
RESULTS:
Intensive insulin therapy maintained HbA(1C) below 7% at all time points during the 2-year follow-up, though it was not necessary to increase the insulin dose, thus highlighting the clinical utility of the therapy in preventing diabetic complications. Insulin therapy could be withdrawn from more than 25% of patients. The diabetic morbid period was shorter and urinary C-peptide level at admission was higher in patients of the withdrawal group than those of the non-withdrawal group, suggesting that patients with well maintained pancreatic β cell reserve could be withdrawn from insulin therapy.
CONCLUSIONS:
Based on our results of the efficacy of strict glycemic control for preventing the development and progression of diabetic complications, we recommend early introduction of intensive insulin therapy to achieve better glycemic control.
AuthorsMasao Toyoda, Tomoya Umezono, Makiko Abe, Keiko Kobayashi, Mayuko Kato, Katsuhiko Yoshino, Takako Kobayashi, Masaaki Miyauchi, Naoyuki Yamamoto, Moritsugu Kimura, Mayumi Maruyama, Masashi Honma, Mitsunori Yagame, Daisuke Suzuki
JournalThe Tokai journal of experimental and clinical medicine (Tokai J Exp Clin Med) Vol. 33 Issue 2 Pg. 95-9 (Jul 20 2008) ISSN: 2185-2243 [Electronic] Japan
PMID21318975 (Publication Type: Journal Article)
Chemical References
  • Blood Glucose
  • C-Peptide
  • Insulin
Topics
  • Adult
  • Aged
  • Asian People
  • Blood Glucose (metabolism)
  • C-Peptide (urine)
  • Diabetes Complications
  • Diabetes Mellitus, Type 2 (drug therapy)
  • Female
  • Humans
  • Insulin (therapeutic use)
  • Male
  • Middle Aged
  • Patient Education as Topic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: